QMF149

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2013-2015
01220132015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
This single-dose, 4-period crossover study evaluated the pharmacokinetics (PK) of the β2 -agonist indacaterol maleate and the… (More)
Is this relevant?
2016
2016
PURPOSE QMF149 is a fixed-dose combination of the long-acting β2 agonist, indacaterol and the corticosteroid, mometasone furoate… (More)
Is this relevant?
2015
2015
OBJECTIVE To investigate the safety and efficacy of QMF149, a once-daily, fixed-dose combination of the long-acting β2-agonist… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2015
2015
OBJECTIVES This study aimed to evaluate influence of ethnic factors on the pharmacokinetics of orally inhaled QMF149, a novel… (More)
Is this relevant?
Review
2013
Review
2013
Chronic obstructive pulmonary disease (COPD) is a debilitating lung disease characterized by airflow limitation and chronic… (More)
Is this relevant?